Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$71.48 - $86.85 $4.53 Million - $5.51 Million
-63,400 Reduced 22.61%
217,014 $18 Million
Q1 2022

May 04, 2022

BUY
$74.28 - $92.69 $1.83 Million - $2.28 Million
24,600 Added 9.62%
280,414 $21.6 Million
Q2 2021

Aug 04, 2021

BUY
$75.51 - $84.79 $1.96 Million - $2.2 Million
25,900 Added 11.27%
255,814 $21.3 Million
Q1 2021

May 13, 2021

BUY
$74.73 - $90.69 $5.12 Million - $6.21 Million
68,500 Added 42.44%
229,914 $17.4 Million
Q4 2020

Feb 11, 2021

BUY
$72.61 - $90.2 $1.85 Million - $2.3 Million
25,500 Added 18.76%
161,414 $14.2 Million
Q3 2020

Nov 12, 2020

BUY
$71.87 - $131.03 $4.18 Million - $7.62 Million
58,150 Added 74.78%
135,914 $10.3 Million
Q4 2019

Feb 12, 2020

BUY
$64.27 - $86.37 $5 Million - $6.72 Million
77,764 New
77,764 $6.57 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nan Fung Trinity (Hk) LTD Portfolio

Follow Nan Fung Trinity (Hk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Trinity (Hk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Trinity (Hk) LTD with notifications on news.